Human papillomavirus 18 E6-specific Affibody inhibits cervical cancer cell proliferation and induces apoptosis. [PDF]
Dong H +8 more
europepmc +1 more source
Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model. [PDF]
Ayre M +5 more
europepmc +1 more source
Genetic Variation of HPV53 and the Identification of T-Cell Epitopes. [PDF]
Wang L +7 more
europepmc +1 more source
Preclinical Development of ARV-2001, an Intradermally Administered mRNA-Lipid Nanoparticle Immunotherapeutic for the Treatment of HPV-16-Positive Cervical High-Grade Squamous Intraepithelial Lesions. [PDF]
He Z +5 more
europepmc +1 more source
An entropy-based framework for genomic variability analysis: A South American case study of human papillomavirus. [PDF]
López Leal A +5 more
europepmc +1 more source
Innovations in HPV vaccination and their role in global cervical cancer control: a review. [PDF]
H Chuwa A.
europepmc +1 more source
Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers. [PDF]
Xue L, Li X, Guo X, Xing H, Liu C.
europepmc +1 more source
The polymerase milieu of human papillomavirus. [PDF]
Ylvisaker KR +3 more
europepmc +1 more source
STING agonist 2'3'-cGAMP as an effective adjuvant for HPV16 peptide vaccine enhances anti-tumor immunity in TC-1 mice models. [PDF]
Cun Y +9 more
europepmc +1 more source

